Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Inventory (2016 - 2025)

Icu Medical's Inventory history spans 17 years, with the latest figure at $615.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 5.33% year-over-year to $615.9 million, compared with a TTM value of $615.9 million through Dec 2025, up 5.33%, and an annual FY2025 reading of $615.9 million, up 5.33% over the prior year.
  • Inventory for Q4 2025 was $615.9 million at Icu Medical, down from $622.4 million in the prior quarter.
  • The five-year high for Inventory was $775.3 million in Q2 2023, with the low at $290.2 million in Q4 2021.
  • Average Inventory over 5 years is $585.6 million, with a median of $619.5 million recorded in 2025.
  • Year-over-year, Inventory skyrocketed 139.81% in 2022 and then decreased 17.58% in 2024.
  • Tracing ICUI's Inventory over 5 years: stood at $290.2 million in 2021, then soared by 139.81% to $696.0 million in 2022, then grew by 1.92% to $709.4 million in 2023, then fell by 17.58% to $584.7 million in 2024, then increased by 5.33% to $615.9 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Inventory are $615.9 million (Q4 2025), $622.4 million (Q3 2025), and $616.5 million (Q2 2025).